Shares in ConvaTec (LON:CTEC) rose today despite the medtech company posting first quarter sales that saw sales shrink more than 5%.
The Deeside, U.K.-based company reported sales of $430.6 million for the quarter ended March 31, 6% lower than the $458.2 million it reported during the first quarter of 2018.
The company’s infusion devices division reported sales of $72.9 million, down 2.4% from its reported $74.7 million during the first quarter of 2018.
